Lorazepam use during clinical trials of adults with bipolar mania episodes
Background: Lorazepam has commonly been prescribed to reduce agitation during bipolar 1 mania trials. Its use has varied considerably by trial methodology and in clinical practice. Methods: The extent and amount of lorazepam treatment was recorded and analyzed from available brief, controlled trials...
Main Author: | Daniel J. Safer |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Contemporary Clinical Trials Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2451865423000686 |
Similar Items
-
A systematic review and network meta‐analysis of antimanic drugs for the treatment of acute mania used in Japan
by: Kanako Ishizuka, et al.
Published: (2022-12-01) -
Lorazepam-Induced Memory Deficits
by: J Gordon Millichap
Published: (1989-03-01) -
Rapid Relief of Catatonia in Mood Disorder by Lorazepam and Diazepam
by: Yu-Chi Huang, et al.
Published: (2013-02-01) -
Evidence that changes the way you practice Bipolar Disorder: Mania and depression explained
by: K. Outhoff
Published: (2016-05-01) -
First-episode mania after COVID-19: A case series in Iran
by: Mahdieh Saeidi, et al.
Published: (2023-04-01)